Company facts
- Headquarters
- Boston, Massachusetts
- Most recent report
- 8-K, filed Sep 9, 2026
- Incorporated
- Delaware
- Filings on record
- 68 filings
- On EDGAR
- CIK 1882782
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 2
News 5
Prospectuses and Registrations 5
Ownership 8 of 40
- SCHEDULE 13G Large holder reported a passive stake Jun 5, 2026
- SCHEDULE 13G Large holder reported a passive stake May 18, 2026
- SCHEDULE 13D Large holder reported an active stake May 18, 2026
- SCHEDULE 13D Large holder reported an active stake May 18, 2026
- SCHEDULE 13D Large holder reported an active stake May 15, 2026
- SCHEDULE 13D Large holder reported an active stake May 15, 2026
- 4 Insider reported a trade May 13, 2026
- 4 Insider reported a trade May 12, 2026
Other 8 of 16
- EFFECT Notice that a registration became effective May 7, 2026
- S-1MEF May 7, 2026
- CERT Exchange certified a listing May 7, 2026
- 8-A12B Registration of a security for exchange listing May 5, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Apr 3, 2026
- DRS/A Draft registration statement, submitted confidentially, amended Mar 16, 2026
- DRS Draft registration statement, submitted confidentially Feb 6, 2026
- D Dec 4, 2025
Everything here comes from Odyssey Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.